Jun 2014
Por:Biominas Brasil
BIO Latin America | Biominas | Businesses | Events | Innovation
Time: 3:45PM – 5:00PM
Location: Room 4 Translation is available in English/Portuguese/Spanish Special thanks to Kira Alvarez of AbbVie for organizing this session. Description: Pharmacovigilance regimes are an important part of the risk management plans required by the new biologics and biosimilars regulations being implemented throughout the region and play a key role in ensuring patient safety. Panel will provide a perspective on how patient groups and the stakeholders interacting with them view the importance of pharmacovigilance, as well as a candid assessment of the challenges in the region with suggested next steps and calls to action. ConfirmedTime: 4:30PM – 5:45PM
Location: Room 5A Description: The TPP negotiations, now in their fourth year, bring together the United States, Japan, and 10 other Asia Pacific economies to lower barriers to commerce, improve intellectual property rights, and expand cross-border collaboration. This session will review the negotiations and its broad-ranging implications. In particular the panel will discuss aspects of the agreement which are mission critical for the biotech industry, including changes to Intellectual Property regimes, regulatory harmonization (or the opposite) and market access issues, particularly for new and innovative therapies. Invariably this will traverse hot topics such as biosimilars, gene patenting, data protection, ever-greening and government policies which denude patents of a substantial portion of their value. AcceptedAinda não recebemos comentários. Seja o primeiro a deixar sua opinião.
Leave a Reply